HART Biologicals has partnered with World Thrombosis Day and more than 550 organisations across 80 countries in a united effort to reduce death and disability from thrombosis. 

Thromobosis is the underlying cause of the world’s top three cardiovascular killers: heart attack, stroke and venous thromboembolism (VTE). 

Taking place on October 13, World Thrombosis Day is an annual event led by the International Society on Thrombosis and Haemostasis (ISTH) and carried out by hundreds of organisations holding more than 7,000 events worldwide. 

The focus for World Thrombosis Day 2016 is VTE and increased risk due to hospitalisation. Up to 60 percent of all VTEs occur during or after hospitalisation and VTE is the leading preventable cause of hospital death.1 

“World Thrombosis Day is proud to once again partner with Hart Biologicals,” said Gary Raskob, PhD, Chairman of the World Thrombosis Day Steering Committee. 

“Educational outreach is critical to increasing awareness of VTE and its prevention and treatment to ultimately saving lives.” 

Keighley Larkin, Technical Manager at Hart Biologicals, said: “As a company we are always keen to get involved with awareness events of this nature and we are delighted to be involved once again with WTD. 

“Every single member of staff within Hart Biologicals is fully aware of the dangers associated with thrombososis, and we are all constantly trying to raise awareness amongst others.”

Take control of your health and avoid potentially deadly blood clots: 

* Know the risk factors for VTE, including hospitalisation, surgery and reduced mobility. 

* Ask your health care provider for a VTE risk assessment when admitted to hospital. 

* Know the warning signs of VTE and seek medical attention promptly if experienced. 

Now in its third year, WTD aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. 

WTD’s mission supports the World health Assembly’s global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. 

For more information on World Thrombosis Day, visit www.WorldThrombosisDay.org.